Natixis Advisors’s Sarepta Therapeutics SRPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,137
| Closed | -$1.92M | – | 1639 |
|
|
2024
Q2 | $1.92M | Buy |
+12,137
| New | +$1.92M | ﹤0.01% | 1058 |
|
|
2023
Q4 | – | Sell |
-26,026
| Closed | -$3.16M | – | 1566 |
|
|
2023
Q3 | $3.16M | Buy |
26,026
+160
| +0.6% | +$19.4K | 0.01% | 843 |
|
|
2023
Q2 | $2.96M | Sell |
25,866
-1,119
| -4% | -$128K | 0.01% | 861 |
|
|
2023
Q1 | $3.72M | Buy |
26,985
+131
| +0.5% | +$18.1K | 0.01% | 777 |
|
|
2022
Q4 | $3.48M | Buy |
26,854
+506
| +2% | +$65.6K | 0.01% | 780 |
|
|
2022
Q3 | $2.91M | Buy |
26,348
+1,416
| +6% | +$157K | 0.01% | 782 |
|
|
2022
Q2 | $1.87M | Sell |
24,932
-2,218
| -8% | -$166K | 0.01% | 930 |
|
|
2022
Q1 | $2.12M | Buy |
27,150
+1,656
| +6% | +$129K | 0.01% | 946 |
|
|
2021
Q4 | $2.3M | Buy |
25,494
+724
| +3% | +$65.2K | 0.01% | 907 |
|
|
2021
Q3 | $2.29M | Buy |
24,770
+634
| +3% | +$58.6K | 0.01% | 885 |
|
|
2021
Q2 | $1.88M | Buy |
24,136
+4,527
| +23% | +$352K | 0.01% | 927 |
|
|
2021
Q1 | $1.46M | Sell |
19,609
-832
| -4% | -$62K | 0.01% | 962 |
|
|
2020
Q4 | $3.49M | Buy |
20,441
+8,231
| +67% | +$1.4M | 0.02% | 682 |
|
|
2020
Q3 | $1.72M | Buy |
12,210
+461
| +4% | +$64.8K | 0.01% | 835 |
|
|
2020
Q2 | $1.88M | Sell |
11,749
-1,486
| -11% | -$238K | 0.01% | 824 |
|
|
2020
Q1 | $1.3M | Sell |
13,235
-352
| -3% | -$34.4K | 0.01% | 840 |
|
|
2019
Q4 | $1.75M | Buy |
+13,587
| New | +$1.75M | 0.01% | 837 |
|